Adage Capital Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-600,000
| Closed | -$13.8M | – | 1096 |
|
|
2020
Q4 | $13.8M | Sell |
600,000
-471,946
| -44% | -$10.9M | 0.03% | 515 |
|
|
2020
Q3 | $10.9M | Sell |
1,071,946
-324,223
| -23% | -$3.3M | 0.03% | 507 |
|
|
2020
Q2 | $20.8M | Buy |
1,396,169
+900,000
| +181% | +$13.4M | 0.05% | 377 |
|
|
2020
Q1 | $6.05M | Hold |
496,169
| – | – | 0.02% | 551 |
|
|
2019
Q4 | $7.85M | Sell |
496,169
-16,000
| -3% | -$253K | 0.02% | 568 |
|
|
2019
Q3 | $6.29M | Sell |
512,169
-123,158
| -19% | -$1.51M | 0.02% | 595 |
|
|
2019
Q2 | $8.39M | Buy |
+635,327
| New | +$8.39M | 0.02% | 551 |
|